Interview With Janssen Doctor Explores Potential Bladder Cancer

Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.

Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective

FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation

Role of biomarkers, targeted therapy and tumour mutations in the landscape of bladder cancer - ecancer

Protocol of the Comparison of Intravesical Therapy and Surgery as

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Cancers, Free Full-Text

Surgical Expertise & Immunotherapy Expand Options for Advanced Bladder Cancer

Discussing tools and resources to support the bladder cancer patient community

The Fascinating Story Behind a New Bladder Cancer Treatment

Interview With Janssen Doctor Explores Potential Bladder Cancer Treatment Options

Bladder Cancer, Causes of Incontinence